Publications
5813 Results
- Journal / Conference
- Journal of the National Cancer Institute Monographs Mar 1;2025(68):22-29
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39989043
- PMC
- PMC11848030
Design and Analysis Considerations for Investigating Patient Subgroups of Interest Within Cancer Clinical Trials
- Journal / Conference
- JNCI Cancer Spectr. 2025 Apr 30;9(3):pkaf033. doi: 10.1093/jncics/pkaf033.
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery and Leukemia
- PMID
- PMID40238217
- PMC
- PMC12121638
Guideline-Concordant Treatment among Adolescents and Young Adults (AYAs) with Acute Lymphoblastic Leukemia (ALL)
- Journal / Conference
- Journal for ImmunoTherapy of Cancer 2025 Jun 30;13(6):e011760. doi: 10.1136/jitc-2025-011760
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID40588371
- PMC
- PMC12211841
- Study Number(s)
- S1609
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: Pancreatic Neuroendocrine Neoplasm (PNEN) Cohort
- Journal / Conference
- Journal of Clinical Oncology; JCO2500204; epub 16 Jun 2025. Sep 20;43(27):2968-2973. doi: 10.1200/JCO-25-00204.
- Year
- 2025
- Research Committee(s)
- Lymphoma
- PMID
- PMID40523203
- Study Number(s)
- S1826
Nivolumab-AVD versus brentuximab vedotin-AVD in older patients with advanced stage classic Hodgkin lymphoma
- Journal / Conference
- Future Oncol. 2025 May;21(11):1325-1331
- Year
- 2025
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID40155326
- PMC
- PMC12051544
- Study Number(s)
- S2303
S2303: phase II/III trial of paclitaxel + ramucirumab +/- nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
- Journal / Conference
- JCO Oncology Advances
- Year
- 2025
- Research Committee(s)
- Lymphoma
- PMID
- PMID40264918
- PMC
- PMC12011429
- Study Number(s)
- S2308
SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma
- Journal / Conference
- Clinical Trials 2025 Oct;22(5):571-577. doi: 10.1177/17407745251321371. Epub 2025 Mar 18.
- Year
- 2025
- Research Committee(s)
- Melanoma
- PMID
- PMID40099861
- PMC
- PMC12353050
- Study Number(s)
- S1801
Design considerations for randomized comparisons of neoadjuvant-adjuvant versus adjuvant-only cancer immunotherapy when tumor measurement schedules do not align (SWOG S1801)
- Journal / Conference
- Journal of the National Cancer Institute Monographs Mar 1;2025(68):56-64
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39989035
- PMC
- PMC11848037
- Study Number(s)
- S1415CD
Practical design considerations for cluster randomized controlled trials: lessons learned in community oncology research
- Journal / Conference
- NPJ Digital Medicine
- Year
- 2025
- Research Committee(s)
- Genitourinary
- PMID
- PMID40121304
- PMC
- PMC11929913
- Study Number(s)
- S1314
Predicting Clinical Outcomes in the S1314-COXEN Trial Using a Multimodal Deep Learning Model Integrating Histopathology, Cell Types, and Gene Expression
- Journal / Conference
- Pediatric Blood & Cancer 2025 Apr;72(4):e31568. doi: 10.1002/pbc.31568. Epub 2025 Jan 25.
- Year
- 2025
- PMID
- PMID39865348